SBL
AMGN icon

Sargent Bickham Lagudis’s Amgen AMGN Stock Holding History

Sargent Bickham Lagudis’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$450K Sell
1,714
-14
-0.8% -$3.75K 0.04% 194
2022
Q3 		$390K Hold
1,728
– – 0.03% 189
2022
Q2 		$420K Buy
1,728
+15
+0.9% +$3.68K 0.04% 190
2022
Q1 		$415K Sell
1,713
-14
-0.8% -$3.22K 0.03% 195
2021
Q4 		$389K Sell
1,727
-23
-1% -$4.85K 0.03% 189
2021
Q3 		$372K Sell
1,750
-53
-3% -$12.2K 0.03% 191
2021
Q2 		$440K Sell
1,803
-139
-7% -$34.2K 0.04% 184
2021
Q1 		$483K Buy
1,942
+75
+4% +$17.9K 0.04% 162
2020
Q4 		$429K Buy
1,867
+336
+22% +$77.5K 0.04% 173
2020
Q3 		$389K Hold
1,531
– – 0.04% 162
2020
Q2 		$361K Hold
1,531
– – 0.04% 158
2020
Q1 		$310K Sell
1,531
-66
-4% -$14.4K 0.04% 168
2019
Q4 		$385K Buy
1,597
+33
+2% +$7.27K 0.04% 161
2019
Q3 		$303K Buy
1,564
+44
+3% +$8.45K 0.04% 161
2019
Q2 		$280K Sell
1,520
-23
-1% -$4.12K 0.03% 178
2019
Q1 		$293K Hold
1,543
– – 0.03% 185
2018
Q4 		$300K Hold
1,543
– – 0.04% 171
2018
Q3 		$320K Hold
1,543
– – 0.04% 169
2018
Q2 		$285K Sell
1,543
-10
-0.6% -$1.77K 0.04% 171
2018
Q1 		$265K Hold
1,553
– – 0.03% 176
2017
Q4 		$270K Hold
1,553
– – 0.03% 188
2017
Q3 		$290K Sell
1,553
-100
-6% -$17.7K 0.04% 176
2017
Q2 		$285K Sell
1,653
-2
-0.1% -$325 0.04% 173
2017
Q1 		$271K Hold
1,655
– – 0.04% 180
2016
Q4 		$242K Sell
1,655
-37
-2% -$5.57K 0.04% 182
2016
Q3 		$282 Buy
1,692
+9
+0.5% +$1.52K 0.04% 171
2016
Q2 		$256K Buy
1,683
+25
+2% +$3.89K 0.04% 178
2016
Q1 		$249K Buy
+1,658
New +$246K 0.04% 181

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sargent Bickham Lagudis's AMGN Position: Q4 2022 in Review

Sargent Bickham Lagudis reduced its Amgen (AMGN) stake by 0.81% in Q4 2022, selling an estimated $3.75K and leaving 1,714 shares worth $450K. The position accounts for 0.04% of the portfolio, ranked #194.

Sargent Bickham Lagudis first reported a position in AMGN in Q1 2016 and has held it in 28 quarters since. The position peaked at $483K in Q1 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Sargent Bickham Lagudis held 1,714 shares of Amgen worth $450K as of Q4 2022.
  • Sargent Bickham Lagudis sold 14 Amgen shares in Q4 2022, an estimated $3.75K.
  • Amgen made up 0.04% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #194 holding.
  • Sargent Bickham Lagudis first reported a position in Amgen in Q1 2016 and has held it in 28 quarters since.
  • Sargent Bickham Lagudis's Amgen position peaked at $483K in Q1 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.